Delivery Order SPE2DB25D3504-SPE2DB25FVVRX
- Not listed
- The Defense Logistics Agency awarded a $5,317.67 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. This award represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $1,054.55 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 160-25 mg tablets (90-count) on August 19, 2025, with completion scheduled for August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's substantial pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) valued at $5,573.64. This is a firm fixed-price delivery order with no set-aside designation, and the product is scheduled for delivery by July 29, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $10,187.12 delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-25 mg tablets (90-count supply) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price, competitively awarded delivery order represents a small-value pharmaceutical procurement with no set-aside designation. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the delivery at this same location. This award falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,542.97 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-25 mg tablets (90-count supply). This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. As a child delivery order under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Valsartan-HCZ 320-25 mg tablets (90-count) with a ceiling value of $3,727.23. This is a firm fixed price, non-set-aside delivery order that represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $6,356.18 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-25 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $36,196.14 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procedures and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Valsartan-HCTZ 160-25 mg tablets in quantities of 90 units, with a ceiling value of $3,305.82. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 8, 2025. The award was made to AmerisourceBergen Drug Corp at its Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count units) with a ceiling value of $2,651.15. This delivery order, issued under firm fixed-price terms with no set-aside designation, represents a competitively awarded procurement from AmerisourceBergen's existing indefinite delivery contract vehicle with the DLA. The product will be performed at the company's Conshohocken,...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVRXDelivery Order
The Defense Logistics Agency awarded a $2,607.52 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count). This competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of July 28, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies comprehensive pharmaceutical products and medical supplies to support military and veteran healthcare systems. The contract vehicle enables the company to deliver medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating the company's established capacity to fulfill federal pharmaceutical supply requirements at scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/25/25 |